Cargando…

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy

BACKGROUND: Traditional clinical target volume (CTV) definition for pelvic radiotherapy in prostate cancer consists of large volumes being treated with homogeneous doses without fully utilizing information on the probability of microscopic involvement to guide target volume design and prescription d...

Descripción completa

Detalles Bibliográficos
Autores principales: Filimonova, Irina, Schmidt, Daniela, Mansoorian, Sina, Weissmann, Thomas, Siavooshhaghighi, Hadi, Cavallaro, Alexander, Kuwert, Torsten, Bert, Christoph, Frey, Benjamin, Distel, Luitpold Valentin, Lettmaier, Sebastian, Fietkau, Rainer, Putz, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820617/
https://www.ncbi.nlm.nih.gov/pubmed/33489887
http://dx.doi.org/10.3389/fonc.2020.590722
_version_ 1783639255861428224
author Filimonova, Irina
Schmidt, Daniela
Mansoorian, Sina
Weissmann, Thomas
Siavooshhaghighi, Hadi
Cavallaro, Alexander
Kuwert, Torsten
Bert, Christoph
Frey, Benjamin
Distel, Luitpold Valentin
Lettmaier, Sebastian
Fietkau, Rainer
Putz, Florian
author_facet Filimonova, Irina
Schmidt, Daniela
Mansoorian, Sina
Weissmann, Thomas
Siavooshhaghighi, Hadi
Cavallaro, Alexander
Kuwert, Torsten
Bert, Christoph
Frey, Benjamin
Distel, Luitpold Valentin
Lettmaier, Sebastian
Fietkau, Rainer
Putz, Florian
author_sort Filimonova, Irina
collection PubMed
description BACKGROUND: Traditional clinical target volume (CTV) definition for pelvic radiotherapy in prostate cancer consists of large volumes being treated with homogeneous doses without fully utilizing information on the probability of microscopic involvement to guide target volume design and prescription dose distribution. METHODS: We analyzed patterns of nodal involvement in 75 patients that received RT for pelvic and paraaortic lymph node metastases (LNs) from prostate cancer in regard to the new NRG-CTV recommendation. Non-rigid registration-based LN mapping and weighted three-dimensional kernel density estimation were used to visualize the average probability distribution for nodal metastases. As independent approach, the mean relative proportion of LNs observed for each level was determined manually and NRG and non-NRG levels were evaluated for frequency of involvement. Computer-automated distance measurements were used to compare LN distances in individual patients to the spatial proximity of nodal metastases at a cohort level. RESULTS: 34.7% of patients had pelvic LNs outside NRG-consensus, of which perirectal was most common (25.3% of all patients) followed by left common iliac nodes near the left psoas major (6.7%). A substantial portion of patients (13.3%) had nodes at the posterior edge of the NRG obturator level. Observer-independent mapping consistently visualized high-probability hotspots outside NRG-consensus in the perirectal and left common iliac regions. Affected nodes in individual patients occurred in highly significantly closer proximity than at cohort-level (mean distance, 6.6 cm vs. 8.7 cm, p < 0.001). CONCLUSIONS: Based on this analysis, the common iliac level should extend to the left psoas major and obturator levels should extend posteriorly 5 mm beyond the obturator internus. Incomplete coverage by the NRG-consensus was mostly because of perirectal involvement. We introduce three-dimensional kernel density estimation after non-rigid registration-based mapping for the analysis of recurrence data in radiotherapy. This technique provides an estimate of the underlying probability distribution of nodal involvement and may help in addressing institution- or subgroup-specific differences. Nodal metastases in individual patients occurred in highly significantly closer proximity than at a cohort-level, which supports that personalized target volumes could be reduced in size compared to a “one-size-fits-all” approach and is an important basis for further investigation into individualized field designs.
format Online
Article
Text
id pubmed-7820617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78206172021-01-23 The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy Filimonova, Irina Schmidt, Daniela Mansoorian, Sina Weissmann, Thomas Siavooshhaghighi, Hadi Cavallaro, Alexander Kuwert, Torsten Bert, Christoph Frey, Benjamin Distel, Luitpold Valentin Lettmaier, Sebastian Fietkau, Rainer Putz, Florian Front Oncol Oncology BACKGROUND: Traditional clinical target volume (CTV) definition for pelvic radiotherapy in prostate cancer consists of large volumes being treated with homogeneous doses without fully utilizing information on the probability of microscopic involvement to guide target volume design and prescription dose distribution. METHODS: We analyzed patterns of nodal involvement in 75 patients that received RT for pelvic and paraaortic lymph node metastases (LNs) from prostate cancer in regard to the new NRG-CTV recommendation. Non-rigid registration-based LN mapping and weighted three-dimensional kernel density estimation were used to visualize the average probability distribution for nodal metastases. As independent approach, the mean relative proportion of LNs observed for each level was determined manually and NRG and non-NRG levels were evaluated for frequency of involvement. Computer-automated distance measurements were used to compare LN distances in individual patients to the spatial proximity of nodal metastases at a cohort level. RESULTS: 34.7% of patients had pelvic LNs outside NRG-consensus, of which perirectal was most common (25.3% of all patients) followed by left common iliac nodes near the left psoas major (6.7%). A substantial portion of patients (13.3%) had nodes at the posterior edge of the NRG obturator level. Observer-independent mapping consistently visualized high-probability hotspots outside NRG-consensus in the perirectal and left common iliac regions. Affected nodes in individual patients occurred in highly significantly closer proximity than at cohort-level (mean distance, 6.6 cm vs. 8.7 cm, p < 0.001). CONCLUSIONS: Based on this analysis, the common iliac level should extend to the left psoas major and obturator levels should extend posteriorly 5 mm beyond the obturator internus. Incomplete coverage by the NRG-consensus was mostly because of perirectal involvement. We introduce three-dimensional kernel density estimation after non-rigid registration-based mapping for the analysis of recurrence data in radiotherapy. This technique provides an estimate of the underlying probability distribution of nodal involvement and may help in addressing institution- or subgroup-specific differences. Nodal metastases in individual patients occurred in highly significantly closer proximity than at a cohort-level, which supports that personalized target volumes could be reduced in size compared to a “one-size-fits-all” approach and is an important basis for further investigation into individualized field designs. Frontiers Media S.A. 2021-01-08 /pmc/articles/PMC7820617/ /pubmed/33489887 http://dx.doi.org/10.3389/fonc.2020.590722 Text en Copyright © 2021 Filimonova, Schmidt, Mansoorian, Weissmann, Siavooshhaghighi, Cavallaro, Kuwert, Bert, Frey, Distel, Lettmaier, Fietkau and Putz http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Filimonova, Irina
Schmidt, Daniela
Mansoorian, Sina
Weissmann, Thomas
Siavooshhaghighi, Hadi
Cavallaro, Alexander
Kuwert, Torsten
Bert, Christoph
Frey, Benjamin
Distel, Luitpold Valentin
Lettmaier, Sebastian
Fietkau, Rainer
Putz, Florian
The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title_full The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title_fullStr The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title_full_unstemmed The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title_short The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
title_sort distribution of pelvic nodal metastases in prostate cancer reveals potential to advance and personalize pelvic radiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820617/
https://www.ncbi.nlm.nih.gov/pubmed/33489887
http://dx.doi.org/10.3389/fonc.2020.590722
work_keys_str_mv AT filimonovairina thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT schmidtdaniela thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT mansooriansina thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT weissmannthomas thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT siavooshhaghighihadi thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT cavallaroalexander thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT kuwerttorsten thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT bertchristoph thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT freybenjamin thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT distelluitpoldvalentin thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT lettmaiersebastian thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT fietkaurainer thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT putzflorian thedistributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT filimonovairina distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT schmidtdaniela distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT mansooriansina distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT weissmannthomas distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT siavooshhaghighihadi distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT cavallaroalexander distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT kuwerttorsten distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT bertchristoph distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT freybenjamin distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT distelluitpoldvalentin distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT lettmaiersebastian distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT fietkaurainer distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy
AT putzflorian distributionofpelvicnodalmetastasesinprostatecancerrevealspotentialtoadvanceandpersonalizepelvicradiotherapy